FDA: Companies Servicing Products Could Get In Hot Water For Remanufacturing
Executive Summary
A new draft guidance from the US FDA clarifies what it considers to be remanufacturing. Companies remanufacturing devices are regulated by the agency and may require new premarket applications.
You may also be interested in...
FDA Hits Snooze On Remanufacturing Draft Guidance, Cybersecurity Discussion Paper
The US agency is extending public comment periods for a controversial draft guidance and a cybersecurity servicing paper that caution servicers that they could get in hot water for remanufacturing medical devices.
Global Medtech Guidance Tracker: June 2021
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-six documents have been posted on the tracker since its last update.
Software Servicers Can Help Keep Products On Market After Manufacturers Stop Providing Support: US FDA
The agency issued a discussion paper that lays out how third-party servicers could help mitigate cybersecurity threats and keep products on the market.